PUBLISHED DATE : Jul 2020 | Pages : 331
Fill out your details & get your free sample
Clinical Nutrition Market Size, Share, Trends Analysis Report by Route of Administration (Oral, Enteral, and Parenteral), Product Type (Powder, Liquid, and Semi-solid), Age Group (Pediatric and Adult), Application (Malnutrition, Metabolic Disorders, Gastrointestinal Disorders, Cancer, and Others), End-user (Hospitals, Long-Term Care (LTC), Homecare, and Individual), Distribution (Institutional Sales, Supermarkets & Hypermarkets, Pharmacies & Drugstores, Specialty Stores and Online Stores), and Geography (APAC, North America, Europe, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020-2025
331 Pages
163 Tables
118 Charts
5 Regions
15 Countries
24 Companies
7 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE (REVENUE) | USD 83 BILLION (2025) |
| CAGR | 8% (2020-2025) |
| Base Year | 2019 |
| Forecast Year | 2020-2025 |
| Market Segments | Route of Administration (Oral, Enteral, and Parenteral), Product Type (Powder, Liquid, and Semi-solid), Age Group (Pediatric and Adult), Application (Malnutrition, Metabolic Disorders, Gastrointestinal Disorders, Cancer, and Others), End-user (Hospitals, Long-Term Care (LTC), Homecare, and Individual), Distribution (Institutional Sales, Supermarkets & Hypermarkets, Pharmacies & Drugstores, Specialty Stores and Online Stores) |
| Geographic Analysis | North America, APAC, Europe, Latin America, and Middle East & Africa |
| Countries Covered | US, Canada, UK, Germany, France, Spain, China, Japan, South Korea, Australia, India, Brazil, Mexico, Saudi Arabia, and UAE |
The global clinical nutrition market size to cross USD 83 billion by 2025, growing at a CAGR of 8% during the forecast period. The global clinical nutrition product market is likely to grow on account of the increased demand for whey protein nutritional supplements in oral and enteral nutrition segments. Whey protein is rapidly becoming a popular ingredient in clinical applications market owing to the presence of essential amino acids and several bioactive constituents that can support treatment regimens for several health conditions, including sarcopenia, obesity, and malnutrition. Whey protein can provide nutritional supplements to patients under various conditions, including aging and muscle atrophy. These supplements are highly useful in the post-operative recovery phase. Hence, with the growth in the global aging population, where nutrition plays a vital role, the number of people aged above 65 is expected to increase reach 1.5 billion by 2050, which is likely to augur well for the growth of the market.
As an impact of COVID-19, clinical nutritional products and immune health supplements are expected to witness rapid growth between 2020 and 2021. The elderly population and people suffering from diabetes and hypertension have worse clinical and survival outcomes. Thus, the supplements remains significantly important to ensure better survival outcomes for patients suffering from COVID-19.
This research report includes a detailed segmentation by
Powder was the largest segment and accounted for over half of the market share in 2019. As the demand for powder nutritional products is expected to continue during the forecast period, the segment is likely to lead the market. The two other types – semi-solid and liquid – are expected to gain momentum on account of the rise in chronic diseases. These types are expected to be popular in the enteral and parenteral nutrition segment. They accounted for approximately 46% of the market share in 2019. APAC is expected to add $9 billion to the global powder market by 2025. The demand for liquid-form products is likely to gain momentum as there is high absorption of powdered drinks for those patients that suffer from vitamin or minerals deficiencies.
Oral nutrition market and supplements are experiencing rapid growth as consumers and healthcare providers are focusing on wellness and disease prevention. The segment is expected to reach a revenue share of $49 billion by 2025. Pediatric and infant nutrition constitute a majority share for oral clinical supplements, with an increasing number of preterm births and the growing demand for milk-based infant formula.
The growing burden of diseases such as diabetes, cancer, neurological diseases, gastrointestinal disorders, and metabolic conditions is driving the demand for enteral nutrition. The growth in home healthcare centers contributes to the demand for enteral and oral nutritional supplements as these centers handle a large number of chronic and old age patients.
The pediatric nutrition segment dominates the market and accounted for over 63% of the sale in 2019. The increasing number of preterm births and the high prevalence of malnutrition among children are primarily driving the demand for clinical nutrition among children. Although the number of child births is declining worldwide, the growing awareness of pediatric nutrition is expected to grow, which is expected to drive the segment.
The high occurrence of diseases such as sclerosis, stroke, dementia, liver disorders, COPD, and diabetes is projected to drive the demand for oral and enteral nutrition products. Also, the growing elderly population and change in lifestyle patterns are other major factors boosting the growth of the segment.
In 2019, the malnutrition nutritional segment accounted for approximately 46% of the market share across the globe. A large prevalence of malnutrition among hospitalized patients is particularly driving the market. The metabolic nutritional segment constitutes the second-largest share, with approximately over 16% revenue in 2019.
Hospital constitutes the largest end-user for clinical nutrition products across the globe. The rising incidence of chronic diseases along with the growing number of preterm births and surgeries, has led to increased demand for these products, especially in hospitals. The rising incidence of malnutrition among hospitalized patients is another factor driving the demand for nutritional products. Individual patients accounted for a market share of close to 40% in 2019. The medical nutrition market for individual patients is expected to witness the fastest growth during the forecast period.
Supermarkets & hypermarkets, convenience stores, drug stores, pharmacies, specialty stores, independent health stores, direct selling, and online stores are the major distribution channels for clinical nutrition products. Institutional sales are the dominant distribution channel, they are expected to keep the momentum during the forecast period. Supermarkets and hypermarkets accounts for the second-largest share of the market. Major retail channels serve as the major sales sources in western countries. Convenience stores, which contributes a significant share to revenue generation, are growing in India, Indonesia, and Brazil regions. Drug stores and pharmacies are the most preferred outlets after supermarkets & hypermarkets. The online distribution mode has gained momentum post the rapid internet penetration and advances in e-commerce shopping sites.
APAC is expected to emerge as the largest market for clinical nutrition across the globe. Post COVID-19, the China, India, Japan, South Korea regions have offered vital revenue opportunities for the key company profiles. The major factors contributing to the clinical nutrition market growth include an increased prevalence of metabolic disorders, the rise in the geriatric population, and the growing expenditure on the healthcare sector. Branding, advertising, clinically-based solutions, and concentration in supermarkets, pharmacies are other major drivers that can help in market growth. Further, as an impact of COVID-19, the sales in certain regions such as China and the US have increased significantly. Nutritional status is one of the most important factors influencing the outcome of patients with COVID-19. The prevalence of malnutrition among hospitalized patients ranges from 28 to 52%, with the highest incidence recorded in China at 72.8%, followed by Vietnam with 55.7% and India with 42.1%. Hence, the high prevalence of malnutrition among hospitalized patients in these countries is driving the market for clinical nutrition.
The global market is becoming highly consolidated, with a rising number of mergers and acquisitions. Most players enter into mergers and acquisitions due to fragmented nature of the market. Further, due to the possibility of incremental growth, non-traditional players are expected to venture into the clinical nutritional supplement market during the forecast period that can lead to further proliferation among players.
Route of Administration
Geography
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
Fill out your details & get your free sample
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
Want to know more about the report or any specific requirement?
Click to Email +1-312-235-2040
